Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.
Autor: | Geduk A; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Oztas B; Department of Biochemistry, Medical Faculty, Kocaeli University, Kocaeli, Turkey., Eryılmaz BH; Department of İnternal Medicine, Medical Faculty, Kocaeli University, Kocaeli, Turkey., Demirsoy ET; Department of Hematology, Derince Training and Research Hospital, Health Sciences University, Kocaeli, Turkey., Menguc MU; Department of Hematology, Medical Faculty, Bolu Abant İzzet Baysal University, Bolu, Turkey., Unal S; Department of Hematology, Kastamonu Training and Research Hospital, Kastamonu, Turkey., Mersin S; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Polat MG; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Aygun K; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Yenihayat EM; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Albayrak H; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Erol HA; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Balcı S; Department of Biostatistics and Medical Informatics, Medical Faculty, Kocaeli University, Kocaeli, Turkey., Mehtap O; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Tarkun P; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey., Hacihanefioglu A; Department of Hematology, Medical Faculty, Kocaeli University, 11.km, 41380 Umuttepe, Kocaeli, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion [Indian J Hematol Blood Transfus] 2023 Apr; Vol. 39 (2), pp. 220-227. Date of Electronic Publication: 2022 Oct 17. |
DOI: | 10.1007/s12288-022-01574-6 |
Abstrakt: | Purpose: The receptor for advanced glycation end products (RAGE) upregulated during the onset and progression of cancer and bone-related pathologies. In this study, we aimed to investigate the role of serum advanced glycation end products (AGEs), soluble RAGE (sRAGE) and high mobility group box 1 (HMGB1), in multiple myeloma (MM). Methods: AGEs, sRAGE and HMGB1 concentrations of 54 newly diagnosed MM patients and 30 healthy volunteers were measured by ELISA. The estimations were done only once at diagnosis. The medical records of the patients were evaluated. Results: There was no significant difference between the AGEs and sRAGE levels between the patient and control groups (p = 0.273, p = 0.313). In ROC analysis, a HMGB1 cutoff value of > 9170 pg/ml accurately discriminated MM patients (AUC = 0.672, 95% CI 0.561-0.77, p = 0.0034). AGEs level was found to be significantly higher in early-stage disease and HMGB1 in advanced disease (p = 0.022, p = 0.026). High HMGB1 levels were detected in patients whose with better first-line treatment response (p = 0.019). At 36 months, 54% of patients with low AGE were alive, compared to 79% of patients with high AGE (p = 0.055). Patients with high HMGB1 levels tended to have a longer PFS (median 43 mo [95% CI; 20.68-65.31] ) compared to patients with low HMGB1 levels (median 25 mo [95% CI; 12.39-37.6], p = 0.054). Conclusion: In this study, a significant elevation of serum HMGB1 level was found in MM patients. In addition, the positive effects of RAGE ligands on treatment response and prognosis were determined. Competing Interests: Conflict of InterestThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2022, corrected publication 2023Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.) |
Databáze: | MEDLINE |
Externí odkaz: |